TW0002330008 (TW0002330008)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 9/9, Altman Z 15.2 (above 3.0 safe zone threshold). DCF fair value of $1056 implies 47% downside based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits exceptional fundamental quality, characterized by a robust ROIC-WACC spread of +12.7% that signals highly efficient capital allocation relative to its cost of equity. This profitability is underpinned by superior margin expansion, with net margins at 45.1% and gross margins near 60%, driving an elevated DuPont ROE primarily through operational leverage rather than financial distress or excessive turnover volatility. Creditworthiness metrics are pristine, evidenced by a perfect Piotroski F-Score of 9/9 indicating strong balance sheet improvements, alongside an Altman Z-Score of 15.2 and Beneish M-Score of -2.68 that collectively suggest low bankruptcy risk and minimal earnings manipulation concerns.
Despite these operational strengths, the current valuation presents a significant discount relative to intrinsic value models. The stock trades at 30.2x forward earnings, representing a substantial premium compared to its own five-year average of 14.5x and implying aggressive market pricing for future growth. While the DCF model suggests an implied ten-year free cash flow growth rate of nearly 25%, this assumption is not fully reflected in current multiples; instead, the fair value calculation indicates a -47.2% downside gap from present prices, suggesting the market may be overpaying for expected returns given the specific discount rates applied in the valuation framework.
Risk-adjusted performance metrics reveal an anomalous divergence between fundamental quality and factor-based pricing. The stock demonstrates a substantial Fama-French annual alpha of 42.16%, significantly outperforming its risk factors, yet it registers neutral exposure to both value (HML: -0.038) and profitability (RMW: -0.044) factors. This disconnect implies the security is being priced based on idiosyncratic growth expectations rather than traditional value or momentum characteristics, creating a scenario where high operational efficiency coexists with neutral factor premiums that may not fully compensate for the elevated valuation multiple relative to historical norms.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 32% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 10.4% | 12.4% | 14.4% |
|---|---|---|---|
| 2% | $1225 | $981 | $817 |
| 3% | $1353 | $1056 | $865 |
| 4% | $1521 | $1150 | $923 |
Center = base case. Green = >10% upside, Red = >10% downside vs $2380.00.
Pre-computed DCF: WACC=12.4%, terminal growth 3%. Fair value $1056 (-46.9%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-03-17 | $6.0000 | +20.0% |
| 2025-12-11 | $5.0000 | -0.0% |
| 2025-09-16 | $5.0000 | +11.1% |
| 2025-06-12 | $4.5000 | 0.0% |
| 2025-03-18 | $4.5000 | +12.5% |
| 2024-12-12 | $3.9996 | -0.0% |
| 2024-09-12 | $4.0001 | +14.3% |
| 2024-06-13 | $3.4998 | 0.0% |
| 2024-03-18 | $3.4998 | +16.7% |
| 2023-12-14 | $3.0000 | 0.0% |
| 2023-09-14 | $3.0000 | +9.1% |
| 2023-06-15 | $2.7498 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like EMXC or SCHE, the fund manager is mechanically forced to buy or sell TW0002330008 shares regardless of TW0002330008's individual fundamentals. We estimate $10.1B of passive capital is structurally linked to TW0002330008 through 5 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 5 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in TW0002330008 to visualize passive redemption contagion across ETFs and collateral stocks.
If TW0002330008 (TW0002330008) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Samsung Electronics Co., Ltd. (KR7005930003) as the most exposed collateral stock, sharing 3 ETFs with TW0002330008. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 5 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
TW0002330008 Ownership Dynamics
Passive funds hold 1 in every 142 TW0002330008 shares, reducing daily market volatility.
TW0002330008 (TW0002330008) exerts measurable gravity on the passive index market, currently representing 17.2% of the iShares MSCI Emerging Markets ex China ETF (EMXC) and 14.9% of the SCHE (SCHE). Across 5 tracked ETFs, approximately 182M shares (0.7% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest TW0002330008 Exposure
Float lock-up computed from 5 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
TW0002330008 Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for TW0002330008 over the past year sits near $1414.03 (12% of 252-day volume). The current price of $2380.00 trades 68.3% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
TW0002330008 Capital Efficiency
How efficiently does TW0002330008 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
TW0002330008 converts 36% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 64% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 12.7% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| KR7000660001 | 0.551 | 0.612 | Moderate |
| JP3932000007 | 0.522 | 0.539 | Moderate |
| KR7005930003 | 0.517 | 0.633 | Moderate |
| JP3802400006 | 0.500 | 0.493 | Moderate |
| JP3162600005 | 0.491 | 0.594 | Moderate |
| JP3236200006 | 0.466 | 0.537 | Moderate |
| JP3497400006 | 0.417 | 0.517 | Moderate |
| JP3197800000 | 0.410 | 0.453 | Moderate |
| CH0012221716 | 0.353 | 0.386 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare TW0002330008 to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.